(855) 401-5378 [email protected]

COVID-19 Support

Qualified Plan Advisors is closely monitoring the coronavirus outbreak on behalf of our clients. Below you will find our latest resources, policies, and procedures. We hope you are staying safe and healthy in these times.

Articles

Our Response to COVID-19

The COVID-19 pandemic brought about a combination of changes, disruptions, and challenges you’ve likely never experienced. Nearly overnight, you and your employees suddenly needed more help than ever before.

Week-in-Review: Week of 11.23.20

The Bottom Line ● Stocks got back to their winning ways with most major global equity indices advancing. The S&P 500, Dow, and Nasdaq indices were all up more than 2% and the Russell 2000 small cap index gained nearly +4%, its fourth straight weekly gain, now up...

Week-in-Review: Week of 11.16.20

The S&P 500 and Dow couldn’t advance for a third week in a row, but small cap stocks were able to extend their streak to three. The Russell 2000 small cap index has gained about +16% in November. For the second week in a row, markets opened on news of a promising new vaccine, only to fade as the week wore on after new coronavirus cases in the U.S. continued to surge and new lockdown measures were announced by various state and local officials.

Week-in-Review: Week of 11.09.20

The S&P 500 and Dow were up for the second week in a row, but it was small cap stocks that topped the leader board for the second straight week. After delivering + 6.9% last week, the Russell 2000 small cap index added another +6.1% this week. Promising news of a potential COVID‐19 vaccine helped Value oriented stocks trounce Growth stocks. But with cases surging both in the U.S. and abroad, many are wondering if this is just another Value head‐fake.

Share This